Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021

SELL
$155.9 - $187.99 $248,036 - $299,092
-1,591 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$144.0 - $169.39 $36,000 - $42,347
-250 Reduced 13.58%
1,591 $251,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $70,681 - $78,457
450 Added 32.35%
1,841 $305,000
Q3 2020

Nov 17, 2020

BUY
$137.1 - $165.37 $22,758 - $27,451
166 Added 13.55%
1,391 $230,000
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $78,344 - $99,771
700 Added 133.33%
1,225 $168,000
Q1 2020

May 18, 2020

BUY
$92.66 - $144.94 $48,646 - $76,093
525 New
525 $62,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.